FDA and CDC warn that tattoo ink can be hazardous to your health
If you’re among the the 21% of American adults who have tattoos, you might be surprised to learn that there’s no law or regulation that requires tattoo inks to be sterile. The Food and Drug Administration, which has oversight over the inks, treats them like cosmetics and says only that ink manufacturers must use ingredients […]
Read More »Category : News
Appeals Court: FDA Tobacco Warning Label Law Violates Free Speech
A divided U.S. Federal Court of Appeals invalidated a government mandate requiring tobacco companies to place graphic images on their products warning of the dangers of smoking. The majority opinion stated that the requirements were a violation of free speech. The Family Smoking Prevention and Tobacco Control Act of 2009, would have required nine written […]
Read More »Category : News
Hepatitis C drug trial halted after patient death
Previous postAnother Alzheimer’s antibody drug fails large trials Next postCourt upholds federal funding of embryonic stem cell research Nature News Blog Hepatitis C drug trial halted after patient death 24 Aug 2012 | 21:02 BST | Posted by Kat Lougheed | Category: Biology & Biotechnology, Health and medicine Bristol-Myers Squibb has halted development of a […]
Read More »Category : News
Millennium Pharmaceuticals Cambridge expansion tests triggers backlash at development
The explosive growth that has made Cambridge one of the country’s foremost life sciences and technology hubs is meeting resistance from some residents who complain that commercial development is overwhelming city neighborhoods. That opposition has already scored one major victory: stalling a proposed 246,000-square-foot office and lab complex near Central Square that would house drug […]
Read More »Category : News
Big Pharma Knocked Out of the Box – Bristol-Myers’ Hepatitis C Blunder is an Enormous Bonus for Medgenics
Reflecting a nightmare for every pharmaceutical company, Bristol Myers Squibb (NYSE:BMY) halted all clinical trials for its NS5B polymerase inhibitor directed at hepatitis C after it came public that eight patients were hospitalized and one died during treatment. Quite a blow, considering not only that the disorder addresses a potential $20 billion market, but also […]
Read More »Category : News
FDA Warning: Reumofan Supplements Contain Risky Drugs
Consumers searching for a miracle cure for the aches and pains of arthritis should beware: The FDA has issued a new warning about the potential health risks of Reumofan and Reumofan Plus, two products marketed as natural dietary supplements for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions. The FDA said it found […]
Read More »Category : News
FDA Panel to Review Humira Colitis Data
Further studies may be needed to demonstrate clear benefits for the tumor necrosis factor (TNF) inhibitor adalimumab (Humira) in ulcerative colitis, FDA staff suggested. In briefing documents prepared in advance of a meeting of the Gastrointestinal Advisory Committee on Aug. 28, FDA staff reviewers questioned whether a difference in rates of clinical remission of less […]
Read More »Category : News
Abbott Pays More to CEO Than Taxes to US Government
In this era of increasing scrutiny given to ceo compensation, yet another report has taken a look at how some companies are making use of tax laws and how this compares with the payouts given to the c-suite. Specifically, the Institute for Policy Studies has found that 26 companies last year paid more to their […]
Read More »Category : News
US Senate Tells FDA to Increase Antibiotic Monitoring
source Last April, the FDA issued various guidances that were designed to tighten the use of antibiotics in animals that are used to produce food. As part of its plan, the agency hoped to convince drugmakers to voluntarily curtail their “injudicious†use of antibiotics – specifically, labeling changes were sought so that antibiotics are not […]
Read More »Category : News
Using Sex to Sell Eczema Cream?
source Some people still demand standards in their advertising. A UK physician complained to a trade group that enforces an industry code that a recent ad by Genus Pharmaceuticals was “offensive and degrading due to its sexual and titillating picture,†which was used to promote a cream for treating eczema. The ad featured the back […]
Read More »Category : News
